RxDoctor Payments DataLook up a doctor →

Pramod Sethi, MD

Neurology · Greensboro, NCNPI 1972560894

Payments from drug & device makers

$2,887,425in general payments, 2019–2025

Across 556 payments — averaging $5193.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$987K
  • E.r. Squibb & Sons, L.L.C.$909K
  • Janssen Research & Development, LLC$542K
  • Medtronic$201K
  • Bayer$102K
  • Genentech, Inc.$97K
  • plus $49K from 54 others
$13,459in research payments, 2019–2025

Across 8 payments — averaging $1682.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$13K

What the payments were for

  • Consulting fees$8,38818%
  • Speaking & faculty fees$25,97955%
  • Travel & lodging$4,55710%
  • Food & beverage$8,63318%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly27$986,748
E.r. Squibb & Sons, L.L.C.5$909,114
Janssen Research & Development, LLC67$542,412
Medtronic(2 entities)57$200,994
Bayer15$101,535
Genentech, Inc.19$97,424
Boehringer Ingelheim1$23,297
AstraZeneca(2 entities)31$7,023
Abbott9$6,235
W. L. Gore & Associates, Inc.9$4,647
Novartis48$3,101
AbbVie(2 entities)70$846
UCB, Inc.16$395
Biogen22$377
Neurocrine Biosciences, Inc.4$289
Amgen19$288
Pfizer10$164
Jazz Pharmaceuticals Inc.7$162
SK Life Science, Inc.6$147
Sanofi7$137
Otsuka America Pharmaceutical, Inc.6$129
Lundbeck LLC5$127
Takeda Pharmaceuticals U.S.A., Inc.4$110
Bristol Myers Squibb5$109
GE HealthCare6$101
Acadia Pharmaceuticals Inc6$99
Argenx US, Inc.6$98
Lilly USA, LLC5$90
Harmony Biosciences LLC5$88
Acorda Therapeutics, Inc5$86
Neurelis, Inc.4$76
Merz Pharmaceuticals, LLC3$73
Mallinckrodt Hospital Products Inc.3$66
Livanova USA, Inc.1$66
Teva Pharmaceuticals USA, Inc.4$65
CSL Behring3$56
Eisai Inc.3$54
Merz North America, Inc.3$52
Tanabe Pharma America, Inc.3$48
Axsome Therapeutics, Inc.3$47
Genentech USA, Inc.2$42
Alnylam Pharmaceuticals Inc.2$39
Banner Life Sciences, LLC1$29
Greenwich Biosciences, Inc.2$29
Impel Pharmaceuticals Inc.1$25
Avadel CNS Pharmaceuticals, LLC1$24
EMD Serono, Inc.1$23
Microtransponder, Inc.1$21
Collegium Pharmaceutical, Inc.1$21
Philips North America LLC1$21
Bausch Health US, LLC1$19
GRT US Holding, Inc.1$19
Arbor Pharmaceuticals, Inc.1$19
Johnson & Johnson1$17
Vanda Pharmaceuticals Inc.1$17
Upsher-smith Laboratories LLC1$17
Boston Scientific1$15
Kyowa Kirin, Inc.1$15
Amneal Pharmaceuticals LLC1$14
Sunovion Pharmaceuticals Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,887,425 in reported general payments places this provider in the 95th percentile of 566 neurology providers in North Carolina.

See all neurology providers in North Carolina

Medicare billing

Part B allowed, 2024
$78,887
Medicare patients
386
Services billed
668

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
KeppraLevetiracetam15$25,993
Repatha SureclickEvolocumab28$20,882
EliquisApixaban18$13,839
BrilintaTicagrelor18$13,314
Memantine Hcl121$3,046
Levetiracetam ErLevetiracetam46$973
Topiramate99$919
ClopidogrelClopidogrel Bisulfate88$889
Levetiracetam41$676
Atorvastatin Calcium67$646
Divalproex Sodium21$583
Donepezil Hcl78$547
Carbidopa-LevodopaCarbidopa/Levodopa14$539
Rosuvastatin Calcium33$431
Gabapentin56$384

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$164$13,83918 claims
AstraZenecaBrilinta$7,023$13,31418 claims
Upsher-smith Laboratories LLCTopiramate$17$91999 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 566 neurology providers in North Carolina.

Other neurology in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →